Circulating CD34 + Fibroblast Progenitors Engaged in Heart Fibrosis of Allograft
Circulation Research · 13.02.2026 · 138 (4)
DOI: 10.1161/circresaha.125.326558 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation Research, erschienen am 13.02.2026. Verfasst von Xiaotong Sun und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, the First Affiliated Hospital (X.S., T.W., H.G., Y.Z., M.C., J.X., G.Y., R.M., T.C., X.G., Q.X.), Zhejiang University Schoo…. Hauptthemen laut MEDLINE: Fibroblasts, Heart Transplantation, Antigens, CD34, Myocardium. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 60 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Fibrosis is one of the major causes of cardiac allograft malfunction and is mainly driven by fibroblasts. However, the role of recipient-derived cells in generating allograft fibroblasts and the underlying mechanisms remain to be explored. METHODS: We analyzed human heart allograft samples and used murine transplant models (C57BL/6J, Cd34 (cluster of differentiation 34)-CreER T2 ; R26-tdTomato, mRFP (cell membrane labeled with red fluorescence protein) mice, Rosa26-iDTR, Postn -CreER T2 ; R26-tdTomato, double-tdTomato, and immunodeficient mice with BALB/c donors). Human progenitor cells were cultivated from blood. Single-cell RNA sequencing, Western blotting, quantitative polymerase chain reaction, and immunohistochemistry, whole-mount staining with 3-dimensional reconstruction, and in vivo / in vitro experiments were applied to characterize allograft cellular composition and communication. RESULTS: Single-cell RNA sequencing was introduced to delineate the allograft cell atlas of patients and mice. Y chromosome analysis identified that recipient-derived cells contributed to allograft fibroblasts in both patients and murine models. Combining the genetic cell lineage tracing technique, we found that recipient-derived CD34 + cells could give rise to activated fibroblasts. Bone marrow transplantation and parabiosis models revealed that the recipient's circulating non–bone marrow Cd34 + cells could generate allograft fibroblasts. Human CD34 + cells could differentiate into fibroblasts both in vivo and in vitro. CD34 + fibroblast progenitors were recruited by CXCL12 (C-X-C motif chemokine ligand 12)-ACKR3 (atypical chemokine receptor 3) and MIF (macrophage migration inhibitory factor)-ACKR3 interactions and differentiated via the TGFβ (transforming growth factor beta)/GFPT2 (glutamine-fructose-6-phosphate transaminase 2)/SMAD2/4 (small mother against decapentaplegic 2/4) axis. Ablation of recipient Cd34 + cells reduced activated fibroblasts and alleviated allograft fibrosis. CONCLUSIONS: We identify circulating CD34 + cells as a novel source of fibroblast progenitors that contribute to cardiac allograft fibrosis, suggesting that targeting recipient CD34 + cells could be a novel therapeutic potential for treating cardiac fibrosis after heart transplantation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, the First Affiliated Hospital (X.S., T.W., H.G., Y.Z., M.C., J.X., G.Y., R.M., T.C., X.G., Q.X.), Zhejiang University School of Medicine, Hangzhou, China.
- Nanhu Brain-computer Interface Institute, Hangzhou, China (H.G.).
- Department of Cardiothoracic Surgery, the First Affiliated Hospital (Y.Q., P.T., W.L., H.Z., L.M.), Zhejiang University School of Medicine, Hangzhou, China.
- Alibaba-Zhejiang University Joint Research Center of Future Digital Healthcare, Hangzhou, China (T.C.).
- Department of Cardiology, and Institute for Cardiovascular Development and Regenerative Medicine, Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, China (L.Z.).
- Department of Cardiology, Affiliated Zhejiang Hospital, Zhejiang University School of Medicine, and Zhejiang Key Laboratory of Integrative Chinese and Western Medicine for Diagnosis and Treatment of Circulatory Diseases…
ORCID-Profile: Xiaotong Sun, Ting Wang, Hui Gong, Weidong Li, Ting Chen, Li Zhang, Xiaogang Guo, Wei Mao, Haige Zhao, Liang Ma, Qingbo Xu
Zitieren
APA
Sun, X., Wang, T., Gong, H., Qiu, Y., Zhang, Y., Chen, M., Xue, J., Ye, G., Mou, R., Teng, P., Li, W., Chen, T., Zhang, L., Guo, X., Mao, W., Zhao, H., Ma, L., & Xu, Q. (2026). Circulating CD34 + Fibroblast Progenitors Engaged in Heart Fibrosis of Allograft. Circulation Research, 138(4). https://doi.org/10.1161/circresaha.125.326558
Vancouver
Sun X, Wang T, Gong H, Qiu Y, Zhang Y, Chen M, et al. Circulating CD34 + Fibroblast Progenitors Engaged in Heart Fibrosis of Allograft. Circulation Research. 2026;138(4). doi:10.1161/circresaha.125.326558
BibTeX
@article{Sun2026,
author = {Sun, Xiaotong and Wang, Ting and Gong, Hui and Qiu, Yichao and Zhang, Yuesheng and Chen, Mengjia and Xue, Jianing and Ye, Guoguo and Mou, Rong and Teng, Peng and Li, Weidong and Chen, Ting and Zhang, Li and Guo, Xiaogang and Mao, Wei and Zhao, Haige and Ma, Liang and Xu, Qingbo},
title = {Circulating CD34 + Fibroblast Progenitors Engaged in Heart Fibrosis of Allograft},
journal = {Circulation Research},
year = {2026},
volume = {138},
number = {4},
doi = {10.1161/circresaha.125.326558}
}
EUVIMED